The aim of the present study was to analyze the predictive
value of a broad spectrum of clinical and laboratory parameters
in patients with CS due to AMI treated with
immediate revascularization. To the best of our knowledge,
this is the first prospective investigation in the early phase
of AMI and CS analyzing serial measurements of NtproBNP,
IL-6, and PCT as predictors of 30-day mortality